Concepedia

Darlene R. Giracello

DR

5

Publications

430

Citations

5

H-Index

2001

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

General Atomics (United States)

Darlene R. Giracello is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in neuropharmacology, medicine, and physiology.

Top concepts

Publications per year

2001–2005

5

Publications

5

In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine)

Jeffery J. Anderson, Margaret Bradbury, Darlene R. Giracello et al. · European Journal of Pharmacology · 2003 · 136 citations

, , +11

[3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine Binding to Metabotropic Glutamate Receptor Subtype 5 in Rodent Brain: In Vitro and in Vivo Characterization

Jeffery J. Anderson, Sara Rao, Blake A. Rowe et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 107 citations · Full text

Metabotropic Glutamate Receptor mGlu5 Is a Mediator of Appetite and Energy Balance in Rats and Mice

Margaret Bradbury, Una C. Campbell, Darlene R. Giracello et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 84 citations

Post-weaning handling attenuates isolation-rearing induced disruptions of prepulse inhibition in rats

Kirsten Krebs-Thomson, Darlene R. Giracello, Arturo Solis et al. · Behavioural Brain Research · 2001 · 54 citations

, , +7

Metabotropic glutamate receptor 5 antagonist-induced stimulation of hypothalamic–pituitary–adrenal axis activity: interaction with serotonergic systems

Margaret Bradbury, Darlene R. Giracello, Deborah F. Chapman et al. · Neuropharmacology · 2003 · 49 citations

, , +13

Rows per page

1–5 of 5